Organization and Function OverviewLilly is investing $4.5 billion in the Lilly Medicine Foundry, a state-of-the-art facility for advanced manufacturing with drug development. The Foundry s mission is to accelerate innovation, expand clinical trial capacity, expedite the delivery of new medicines, and reduce costs and environmental impact. The Process Translation and Execution (PTE) team drives scientific excellence and innovation to accelerate manufacturing advancements. The team translates ...
Synthetic Molecule Design and Development (SMDD) is a critical function within Lilly Product Research Development (PRD) responsible for the development of synthetic drug substances and drug products from the pre-clinical phase through commercialization. Process chemistry is crucial to establishing a robust and sustainable supply chain of the synthetic active ingredients that make up Lilly s portfolio. Our chemists and engineers develop key technical and business solutions across the portfolio ...
Insert additional messaging here.
